← Open Payments lookup

JEAN BAKER: Open Payments

NPI 1386822856 · OAKLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$229 in 11 payments from 8 companies in 2025. Trend: 2023 $394 · 2024 $225 · 2025 $229

Food & beverage: $229
CompanyPaymentsAmount
Alnylam Pharmaceuticals Inc.2$45
Merck Sharp & Dohme LLC2$45
ABBVIE INC.2$33
PFIZER INC.1$24
Astellas Pharma US Inc1$24
AstraZeneca Pharmaceuticals LP1$24
Rhythm Pharmaceuticals, Inc.1$20
Axsome Therapeutics, Inc.1$15

Products named: GIVLAARI, VRAYLAR, TRUMENBA, Veozah, AIRSUPRA, ROTATEQ, VAXNEUVANCE, IMCIVREE.

Industry payments across MD — which companies pay providers there.